Legal News

Businesses appeal £100m CMA fine for overpriced drug

Published on: 22 November 2021
Published by: Law360
  • Businesses appeal £100m CMA fine for overpriced drug

Article summary

Law360, London: Drugmaker Advanz and two other companies have appealed against a £100m (US$134m) fine from UK’s antitrust watchdog for inflating the price of tablets for thyroid conditions by 1,110%. or take a trial to read the full analysis.

Popular documents